Anti-GZMM / Granzyme M

Adding 0.2 ml of distilled water will yield a concentration of 500 ug/ml. GZMM antibody detects Granzyme M, a serine protease expressed in cytotoxic lymphocytes and natural killer (NK) cells that mediates immune defense through target cell apoptosis. The UniProt recommended name is Granzyme M (GZMM). This enzyme contributes to innate immunity by inducing non-caspase-dependent cell death and by modulating inflammatory cytokine processing.Functionally, GZMM antibody identifies a 262-amino-acid protein localized to cytotoxic granules of NK and CD8+ T cells. Granzyme M is stored in secretory vesicles and released upon immune activation to cleave intracellular substrates in infected or malignant cells. It works synergistically with perforin and other granzymes to initiate rapid target cell lysis.The GZMM gene is located on chromosome 19p13.3 within the granzyme gene cluster and is expressed predominantly in NK cells and cytotoxic T lymphocytes. GZMM contributes to immune surveillance by degrading viral and bacterial proteins and modulating proinflammatory signaling pathways.Pathologically, elevated GZMM activity has been observed in inflammatory and autoimmune diseases, as well as in cancer immune responses. Deficiency impairs cytotoxic clearance of pathogens and tumor cells. Research using GZMM antibody supports studies in immunology, cytotoxic signaling, and inflammation control.GZMM antibody is validated for western blotting, flow cytometry, and immunohistochemistry to detect cytotoxic granule enzymes. NSJ Bioreagents provides GZMM antibody reagents optimized for immune cell function, cytotoxicity, and inflammation research.Structurally, Granzyme M is a trypsin-like serine protease containing the catalytic triad His-Asp-Ser and a substrate-binding pocket that determines cleavage specificity. This antibody aids in examining GZMM's role in cytotoxic defense and immune regulation.